3D Bioprinting of Breast Cancer Models for Drug Resistance Study
The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
Adipose-derived mesenchymal stem/stromal cells (ADMSC) are one of the major stromal cells in the breast cancer microenvironment that promote cancer progression. Previous studies on the effects of ADMSC on breast cancer metastasis and drug resistance, using two-dimensional (2D) cultures, remained inconclusive. In the present study, we compared cocultured ADMSC and human epidermal receptor 2 positive breast primary breast cancer cells (21PT) in 2D and three-dimensional (3D) cultures and then examined their response to doxorubicin (DOX). We examined 3D bioprinted constructs with breast cancer cells in the middle and ADMSC in the edge region, which were made by using dual hydrogel-based bioinks. We found that the percentage of cleaved Caspase-3 positive cells was significantly lower in the bioprinted constructs with ADMSC and 21PT than that in the cancer cell alone constructs, in response to low DOX dose. We further increased the thickness of the ADMSC layers to mimic the status of obesity and then examined the effect of ADMSC thickness on DOX resistance and lysyl oxidase (LOX) secretion. In the moderate and thick-layered ADMSC constructs, significantly more cells were stained negative for cleaved Caspase-3, indicating less apoptosis. Both ADMSC and 21PT intrinsically expressed LOX, regardless of changes in thickness or DOX administration. Notably, treatment with a LOX inhibitor significantly decreased the stiffness in the ADMSC region but did not affect the stiffness in the 21PT region. In addition, LOX inhibitor treatment enhanced DOX sensitivity of 21PT in the bioprinted constructs, as seen by a decrease in LOX secretion and downregulation of adenosine triphosphate-binding cassette transporter gene expression. Taken together, we demonstrate that 3D bioprinted these breast cancer models faithfully reproduce in vivo conditions and should provide better models for examining breast cancer biology and for screening for drug discoveries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An extensive body of experimental evidence has established that 3D culture systems more closely recapitulate the architecture and the physiology of human solid tumors when compared with traditional 2D systems.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [93]
In the citing paper
“While 2D systems were the first workhorses in cancer research, a vast body of experimental evidence confirms that the relevant features of the cancer progression, and the effectiveness of anticancer pharmaceutical compounds, cannot be properly recapitulated in 2D cell culture systems [8,57,93].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [93]
In the citing paper
“In recent years, bioprinting technology based on layer-by-layer printing has been used for tumor-on-a-chip fabrication (Fig. 3)132,145–147.”
From Tumor-on-a-chip: from bioinspired design to biomedical application (2021) · cites this paper as [145]
Citations
Cites
1 retracted
Cox, T. R., Rumney, R. M. H., Schoof, E. M., Perryman, L., Høye, A. M., Agrawal, A., Bird, D., Latif, N. A., Forrest, H., Evans, H. R., et al. (2015) · Nature · doi:10.1038/nature14492 · Cited by 482
RetractedMicroenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
A 3D bioprinting system to produce human-scale tissue constructs with structural integrity
Kang, H.-W., Lee, S. J., Ko, I. K., Kengla, C., Yoo, J. J., & Atala, A. (2016) · Nature Biotechnology · doi:10.1038/nbt.3413 · Cited by 2,622
3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs
Kolesky, D. B., Truby, R. L., Gladman, A. S., Busbee, T. A., Homan, K. A., & Lewis, J. A. (2014) · Advanced Materials · doi:10.1002/adma.201305506 · Cited by 2,102
HIF-1α pathway: role, regulation and intervention for cancer therapy
Masoud, G. N., & Li, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.007 · Cited by 1,871
Modeling Tissue Morphogenesis and Cancer in 3D
Yamada, K. M., & Cukierman, E. (2007) · Cell · doi:10.1016/j.cell.2007.08.006 · Cited by 1,751
Research works printed but not linked: 2
- Kirschmann D., 2002, Cancer Res., 62, 4478
- Band V., 1990, Cancer Res., 50, 7351
Cited by
Fundamentals and Applications of Photo-Cross-Linking in Bioprinting
Lim, K. S., Galarraga, J. H., Cui, X., Lindberg, G. C. J., Burdick, J. A., & Woodfield, T. B. F. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00812 · Cited by 416
Daly, A. C., Prendergast, M. E., Hughes, A. J., & Burdick, J. A. (2021) · Cell · doi:10.1016/j.cell.2020.12.002 · Cited by 332
3D bioprinting for reconstituting the cancer microenvironment
Datta, P., Dey, M., Ataie, Z., Unutmaz, D., & Ozbolat, I. T. (2020) · npj Precision Oncology · doi:10.1038/s41698-020-0121-2 · Cited by 304
Barbosa, M. A. G., Xavier, C. P. R., Pereira, R. F., Petrikaitė, V., & Vasconcelos, M. H. (2021) · Cancers · doi:10.3390/cancers14010190 · Cited by 285
“Amongst the scaffold-based methods available, the extrusion-based 3D bioprinting (Figure 2J) allows the layer-by-layer deposition of cells, biomaterials, and biochemical factors into 3D constructs with predesigned features, therefore allowing the creation of geometrically complex scaffolds and biomimetic tissue models…”
BackgroundMethodInfluentialTumor-on-a-chip: from bioinspired design to biomedical application
Liu, X., Fang, J., Huang, S., Wu, X., Xie, X., Wang, J., Liu, F., Zhang, M., Peng, Z., & Hu, N. (2021) · Microsystems & Nanoengineering · doi:10.1038/s41378-021-00277-8 · Cited by 246
Extrusion bioprinting of soft materials: An emerging technique for biological model fabrication
Jiang, T., Munguia-Lopez, J. G., Flores-Torres, S., Kort-Mascort, J., & Kinsella, J. M. (2019) · Applied Physics Reviews · doi:10.1063/1.5059393 · Cited by 243
Advances in 3D bioprinting of tissues/organs for regenerative medicine and in-vitro models
Jain, P., Kathuria, H., & Dubey, N. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121639 · Cited by 237
Breast cancer models: Engineering the tumor microenvironment
Bahcecioglu, G., Basara, G., Ellis, B. W., Ren, X., & Zorlutuna, P. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.02.006 · Cited by 213
3D bioprinting and its innovative approach for biomedical applications
Tripathi, S., Mandal, S. S., Bauri, S., & Maiti, P. (2023) · MedComm · doi:10.1002/mco2.194 · Cited by 206
3D Bioprinted cancer models: Revolutionizing personalized cancer therapy
Augustine, R., Kalva, S. N., Ahmad, R., Zahid, A. A., Hasan, S., Nayeem, A., McClements, L., & Hasan, A. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101015 · Cited by 195
“[20] with the permission of American Chemical Society.”
BackgroundMethodInfluentialFabrication of versatile dynamic hyaluronic acid-based hydrogels
Shi, W., Hass, B., Kuss, M. A., Zhang, H., Ryu, S., Zhang, D., Li, T., Li, Y.-L., & Duan, B. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115803 · Cited by 191
Self-citationTrujillo-de Santiago, G., Flores-Garza, B. G., Tavares-Negrete, J. A., Lara-Mayorga, I. M., González-Gamboa, I., Zhang, Y. S., Rojas-Martínez, A., Ortiz-López, R., & Álvarez, M. M. (2019) · Materials · doi:10.3390/ma12182945 · Cited by 184
“A few bioprinting techniques have been reported for the fabrication of tumor spheroids [93,142,144,168].”
BackgroundInfluential3D bioprinting: current status and trends—a guide to the literature and industrial practice
Santoni, S., Gugliandolo, S. G., Sponchioni, M., Moscatelli, D., & Colosimo, B. M. (2022) · Bio-Design and Manufacturing · doi:10.1007/s42242-021-00165-0 · Cited by 167
Shi, W., Kong, Y., Su, Y., Kuss, M. A., Jiang, X., Li, X., Xie, J., & Duan, B. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00156f · Cited by 160
Self-citationCell Culture Based in vitro Test Systems for Anticancer Drug Screening
Kitaeva, K. V., Rutland, C. S., Rizvanov, A. A., & Solovyeva, V. V. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00322 · Cited by 142
The past, present, and future of breast cancer models for nanomedicine development
Boix-Montesinos, P., Soriano‐Teruel, P. M., Armiñán, A., Orzáez, M., & Vicent, M. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.018 · Cited by 159
Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling
Shukla, P., Yeleswarapu, S., Heinrich, M. A., Prakash, J., & Pati, F. (2022) · Biofabrication · doi:10.1088/1758-5090/ac6d11 · Cited by 148
Biofabrication methods for reconstructing extracellular matrix mimetics
Aazmi, A., Zhang, D., Mazzaglia, C., Yu, M., Wang, Z., Yang, H., Huang, Y. Y. S., & Ma, L. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.08.018 · Cited by 130
Current research progress of photopolymerized hydrogels in tissue engineering
Sun, A., He, X., Xiao, J., Hu, D., Pan, M., Zhang, L., & Qian, Z. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.01.048 · Cited by 128
3D printed composite scaffolds with dual small molecule delivery for mandibular bone regeneration
Zhang, W., Shi, W., Wu, S., Kuss, M. A., Jiang, X., Untrauer, J. B., Reid, S. P., & Duan, B. (2020) · Biofabrication · doi:10.1088/1758-5090/ab906e · Cited by 119
“The relative expression of each target gene was calculated using the comparative Ct (2 −ΔΔCt) method [47].”
MethodSelf-citationSalemme, V., Centonze, G., Avalle, L., Natalini, D., Piccolantonio, A., Arina, P., Morellato, A., Ala, U., Taverna, D., Turco, E., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1170264 · Cited by 123
“The authors proposed the use of this 3D model for chemoresistance studies (134).”
MethodShi, W., Fang, F., Kong, Y., Greer, S. E., Kuss, M. A., Liu, B., Xue, W. L., Jiang, X., Lovell, P., Mohs, A. M., et al. (2021) · Biofabrication · doi:10.1088/1758-5090/ac42de · Cited by 110
“The cytotoxicity was tested by an MTT ([3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Sigma) assay [34, 35].”
Self-citationBioprinting of in vitro tumor models for personalized cancer treatment: a review
Mao, S., Pang, Y., Liu, T., Shao, Y., He, J., Yang, H., Mao, Y., & Sun, W. (2020) · Biofabrication · doi:10.1088/1758-5090/ab97c0 · Cited by 94
“(B) Fluorescent images of coculture cancer models with different layer thicknesses; ADMSCs in the edge region were labeled with celltracker red, and 21PT cells in the middle region were labeled with celltracker green [92].”
BackgroundMethodShi, W., Mirza, S., Kuss, M. A., Liu, B., Hartin, A., Wan, S., Kong, Y., Mohapatra, B. C., Krishnan, M. A., Band, H., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300905 · Cited by 102
Self-citationBlanco‐Fernandez, B., Rey-Viñolas, S., Bağcı, G., Rubí-Sans, G., Otero, J., Navajas, D., Pérez‐Amodio, S., & Engel, E. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c00920 · Cited by 88
Addressing Patient Specificity in the Engineering of Tumor Models
Bray, L. J., Hutmacher, D. W., & Bock, N. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00217 · Cited by 73
Craig, M., Jenner, A. L., Namgung, B., Lee, L. P., & Goldman, A. J. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00356 · Cited by 82
Hwang, D. G., Choi, Y., & Jang, J. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.685507 · Cited by 80
Recent Advances of Organ-on-a-Chip in Cancer Modeling Research
Liu, X., Su, Q., Zhang, X., Yang, W., Ning, J., Jia, K., Xin, J., Li, H., Yu, L., Liao, Y., et al. (2022) · Biosensors · doi:10.3390/bios12111045 · Cited by 75
Shi, W., Jang, S., Kuss, M. A., Alimi, O. A., Liu, B., Palik, J., Tan, L., Krishnan, M. A., Jin, Y., Yu, C., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c12928 · Cited by 66
Self-citationLi, X., Zheng, F., Wang, X., Geng, X., Zhao, S., Liu, H., Dou, D., Leng, Y., Wang, L., & Yubo, F. (2022) · International Journal of Bioprinting · doi:10.18063/ijb.v9i2.649 · Cited by 83
Castro, F., Pereira, C. L., Macedo, M. H., Almeida, A., Silveira, M. J., Dias, S., Cardoso, A. P., Oliveira, M. J., & Sarmento, B. F. C. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.06.001 · Cited by 66
An insight on advances and applications of 3d bioprinting: A review
Bejoy, A. M., Makkithaya, K. N., Hunakunti, B. B., Hegde, A., Krishnamurthy, K., Sarkar, A., Lobo, C. F., Keshav, D. V. S., Gopal, D., Dhivya Dharshini, S., et al. (2021) · Bioprinting · doi:10.1016/j.bprint.2021.e00176 · Cited by 57
Sbirkov, Y., Molander, D., Milet, C., Bodurov, I., Atanasov, B. T., Penkov, R., Belev, N., Forraz, N., McGUCKIN, C. P., & Sarafian, V. S. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.755563 · Cited by 58
Vrana, N. E., Gupta, S., Mitra, K., Rizvanov, A. A., Solovyeva, V. V., Antmen, E., Salehi, M., Ehterami, A., Pourchet, L., Barthès, J., et al. (2022) · Cell and Tissue Banking · doi:10.1007/s10561-021-09975-z · Cited by 57
“They also provide tumor micro-environments with much higher repeatability and reproducibility, which can be translated into more effective anticancer drugs (Wang et al. 2018a).”
BackgroundRecent progress of 4D printing in cancer therapeutics studies
Chinnakorn, A., Nuansing, W., Bodaghi, M., Rolfe, B., & Zolfagharian, A. (2023) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2023.02.002 · Cited by 55
Bioinks for 3D Bioprinting: A Scientometric Analysis of Two Decades of Progress
Pedroza-González, S. C., Rodríguez-Salvador, M., Pérez-Benítez, B. E., Álvarez, M. M., & Santiago, G. T. (2021) · International Journal of Bioprinting · doi:10.18063/ijb.v7i2.337 · Cited by 67
3D bioprinted tumor model with extracellular matrix enhanced bioinks for nanoparticle evaluation
Chen, Y., Xu, L., Li, W., Chen, W., He, Q., Zhang, X., Tang, J., Wang, Y., Liu, B., & Liu, J. (2022) · Biofabrication · doi:10.1088/1758-5090/ac48e4 · Cited by 58
“Some authors have tried fabricating tumor models, including breast cancer [ 24, 25], glioblastoma [26, 27], cervical cancer [28], and prelimin-arily explored the potential of these models in drug screening [29, 30].”
Self-citationThe Variety of 3D Breast Cancer Models for the Study of Tumor Physiology and Drug Screening
Fröhlich, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087116 · Cited by 57
“Further, the presence of the MSCs increased growth and migration of MDA-MB-231 cells in GelMA hydrogel with nanocrystalline hydroxyapatite (nHAp) [154].”
BackgroundInfluential3D Bioprinting: The Emergence of Programmable Biodesign
Carreira, S. C., Begum, R., & Perriman, A. W. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900554 · Cited by 53
The promising rise of bioprinting in revolutionalizing medical science: Advances and possibilities
Jamee, R., Araf, Y., Naser, I. B., & Promon, S. K. (2021) · Regenerative Therapy · doi:10.1016/j.reth.2021.05.006 · Cited by 46
“Another bioprinted model, HER2-positive breast cancer cells encapsulated in adipose-derived mesenchymal stem cells (ADMSCs) were used to assess doxorubicin and study drug resistance [192].”
Method3D bioprinting of engineered breast cancer constructs for personalized and targeted cancer therapy
Sharifi, M., Bai, Q., Babadaei, M. M. N., Chowdhury, F., Hassan, M., Taghizadeh, A., Derakhshankhah, H., Suliman, K., Hasan, A., & Falahati, M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.026 · Cited by 42
Yuan, T., Fu, X., Hu, R., Zheng, X., Jiang, D., Jing, L., Kuang, X., Guo, Z., Xu, L., Liu, Y., et al. (2024) · Trends in biotechnology · doi:10.1016/j.tibtech.2024.06.007 · Cited by 52
3D Bioprinting: An Important Tool for Tumor Microenvironment Research
Li, Y., Liu, J., Xu, S. Q., & Wang, J. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s435845 · Cited by 47
“62 Furthermore, Anna Sebestyén et al utilized alginate-based hydrogel bioinks for 3D bioprinting and long-term cultivation of tumor cells in vitro.”
Fischetti, T., Pompo, G. D., Baldini, N., Avnet, S., & Graziani, G. (2021) · Cancers · doi:10.3390/cancers13164065 · Cited by 45
“complex in vitro cancer and bone models that can replicate different aspects of the 3D tumor microenvironment [36–38] and may be useful for understanding tumor heterogeneity and identify those mechanisms responsible for tumor progression and resistance to therapy [36,39].”
BackgroundAdvances in 3D bioprinting for the biofabrication of tumor models
Sánchez-Salazar, M. G., Álvarez, M. M., & Santiago, G. T. (2020) · Bioprinting · doi:10.1016/j.bprint.2020.e00120 · Cited by 39
Baka, Z., Godier, C., Lamy, L., Mallick, A., Gribova, V., Figarol, A., Bezdetnaya, L., Chateau, A., Magne, Z., Stiefel, M., et al. (2022) · Macromolecular Bioscience · doi:10.1002/mabi.202200434 · Cited by 41
Application of three-dimensional (3D) bioprinting in anti-cancer therapy
Wu, B., Wu, Z. Q., Hou, Y.-Y., Fang, Z.-X., Deng, Y., Wu, H.-T., & Liu, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20475 · Cited by 44
“To mimic in vivo TME, Wang et al. established a 3D bioprinted construct with central BC cells surrounded with ADMSC using dual hydrogel-based bioinks, which reduced the percentage of cleaved caspase-3 positive cells in response to doxorubicin treatment associated with the thickness of ADMSC [117].”
BackgroundDankó, T., Petővári, G., Raffay, R. E., Sztankovics, D., Moldvai, D., Vetlényi, E., Krencz, I., Rókusz, A., Sipos, K., Visnovitz, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137444 · Cited by 37
Chowdhury, T., Cressiot, B., Parisi, C., Smolyakov, G., Thiébot, B., Trichet, L., Fernandes, F. M., Pelta, J., & Manivet, P. (2023) · ACS Sensors · doi:10.1021/acssensors.2c02308 · Cited by 34
3D bioprinting technology to mimic the tumor microenvironment: tumor-on-a-chip concept
Samadian, H., Jafari, S., Sepand, M. R., Alaei, L., Malvajerd, S. S., Jaymand, M., Ghobadinezhad, F., Jahanshahi, F., Hamblin, M. R., Derakhshankhah, H., et al. (2021) · Materials Today Advances · doi:10.1016/j.mtadv.2021.100160 · Cited by 36
Abolhassani, H., Eskandari, A., Poor, A. S., Zarrabi, A., Khodadadi, B., Karimifard, S., Sahrayi, H., Bourbour, M., & Yaraki, M. T. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.215754 · Cited by 36
Recent Advances in 3D Bioprinted Tumor Microenvironment
Bae, J., Han, S., & Park, S. (2020) · BioChip Journal · doi:10.1007/s13206-020-4201-8 · Cited by 33
Wu, D., Berg, J., Arlt, B., Röhrs, V., Al‐Zeer, M. A., Deubzer, H. E., & Kurreck, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010122 · Cited by 32
“The response was found to depend on the thickness of the ADMSC layer, demonstrating the importance of the tumor environment.”
BackgroundKey aspects for conception and construction of co-culture models of tumor-stroma interactions
Mason, J. E., & Öhlund, D. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1150764 · Cited by 32
“Indeed, cancer specific bioprinted models exist for breast (Wang et al., 2018), brain (Heinrich et al.”
BackgroundRastin, H., Mansouri, N., Tùng, T. T., Hassan, K., Mazinani, A., Ramezanpour, M., Yap, P. L., Yu, L., Vreugde, S., & Lošić, D. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101439 · Cited by 36
Pagnotta, G., Kalia, S., Lisa, L. D., Cicero, A. F. G., Borghi, C., & Focarete, M. L. (2022) · Bioprinting · doi:10.1016/j.bprint.2022.e00218 · Cited by 34
Application of 3D, 4D, 5D, and 6D bioprinting in cancer research: what does the future look like?
Khorsandi, D., Rezayat, D., Sezen, S., Ferrao, R., Khosravi, A., Zarepour, A., Khorsandi, M., Hashemian, M. A., Iravani, S., & Zarrabi, A. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00310a · Cited by 35
González‐Callejo, P., García‐Astrain, C., Herrero‐Ruiz, A., Henriksen‐Lacey, M., Seras‐Franzoso, J., Abasolo, I., & Liz‐Marzán, L. M. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c04135 · Cited by 34
3D Bioprinting for Oncology Applications
Liu, T., Delavaux, C., & Zhang, Y. S. (2019) · Journal of 3D Printing in Medicine · doi:10.2217/3dp-2019-0004 · Cited by 31
“Moreover, a 3D bioprinted model of HER2-positive breast cancer embedded in a matrix of adipose-derived mesenchymal stem cells (ADMSCs) was used to examine its response to doxorubicin and associated drug resistance [18].”
MethodDar, M. S., Rosaiah, P., Bhagyalakshmi, J., Ahirwar, S., Khan, A., Tamizhselvi, R., Reddy, V. R. M., Palaniappan, A., & Sahu, N. K. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216247 · Cited by 27
Cell Bioprinting: The 3D-Bioplotter™ Case
Lobo, D. A., & Ginestra, P. S. (2019) · Materials · doi:10.3390/ma12234005 · Cited by 35
Piotrowska, U., Tsoi, J. K. H., Singh, P., Banerjee, A., & Sobczak, M. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01062 · Cited by 34
Tackling Current Biomedical Challenges With Frontier Biofabrication and Organ-On-A-Chip Technologies
Celikkin, N., Presutti, D., Maiullari, F., Fornetti, E., Agarwal, T., Paradiso, A., Volpi, M., Święszkowski, W., Bearzi, C., Barbetta, A., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.732130 · Cited by 26
Bioprinting and its Use in Tumor-On-A-Chip Technology for Cancer Drug Screening: A Review
Fang, L., Liu, Y., Qiu, J., & Wan, W. (2022) · International Journal of Bioprinting · doi:10.18063/ijb.v8i4.603 · Cited by 28
Printing of 3D biomimetic structures for the study of bone metastasis: A review
Khanmohammadi, M., Volpi, M., Walejewska, E., Olszewska, A., & Święszkowski, W. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.02.046 · Cited by 25
The biology and engineered modeling strategies of cancer-nerve crosstalk
Gregory, E., Dugan, R., David, G., & Song, Y. H. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188406 · Cited by 23
Perspectives for 3D-Bioprinting in Modeling of Tumor Immune Evasion
Staros, R., Michalak, A., Rusinek, K., Mucha, K., Pojda, Z., & Zagożdżon, R. (2022) · Cancers · doi:10.3390/cancers14133126 · Cited by 25
“Methacrylated hyaluronic acid and gelatin EBB Increased final mechanical strength by methacrylation photocrosslinking Breast tumor model [58]”
BackgroundBreast cancer brain metastasis: from etiology to state-of-the-art modeling
Kamalabadi‐Farahani, M., Gharibshahian, M., Rezvani, A., & Vaez, A. (2023) · Journal of Biological Engineering · doi:10.1186/s13036-023-00352-w · Cited by 28
Núñez-Olvera, S. I., Aguilar‐Arnal, L., Cisneros-Villanueva, M., Hidalgo‐Miranda, A., Marchat, L. A., Salinas-Vera, Y. M., Ramos‐Payán, R., Pérez‐Plasencia, C., Carlos‐Reyes, Á., Puente-Rivera, J., et al. (2022) · Cells · doi:10.3390/cells11213458 · Cited by 25
Keeping It Organized: Multicompartment Constructs to Mimic Tissue Heterogeneity
Sanchez-Rubio, A., Jayawarna, V., Maxwell, E., Dalby, M. J., & Salmerón‐Sánchez, M. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202110 · Cited by 26
Dynamic Alginate Hydrogel as an Antioxidative Bioink for Bioprinting
Zhang, W., Kuss, M. A., Yan, Y., & Shi, W. (2023) · Gels · doi:10.3390/gels9040312 · Cited by 24
Self-citation3D Tumor Models for Breast Cancer: Whither We Are and What We Need
Balachander, G. M., Kotcherlakota, R., Nayak, B., Kedaria, D., Rangarajan, A., & Chatterjee, K. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00230 · Cited by 23
Flores-Torres, S., Jiang, T., Kort-Mascort, J., Yang, Y. K., Peza-Chavez, O., Pal, S., Mainolfi, A., Pardo, L. A., Ferri, L. E., Bertos, N., et al. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00998 · Cited by 25
Désigaux, T., Comperat, L., Dusserre, N., Stachowicz, M., Lea, M., Dupuy, J., Vial, A., Molinari, M., Fricain, J., Paris, F., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.08.037 · Cited by 43
Liverani, C., Vita, A. D., Spadazzi, C., Miserocchi, G., Cocchi, C., Bongiovanni, A., Lucia, A. D., Manna, F. L., Fabbri, F., Tebaldi, M., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13037 · Cited by 25
Zhou, Y., Yu, F., Guo, M., Tang, Y., & Xu, Q. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1498141 · Cited by 25
Role of In Vitro Models for Development of Ophthalmic Delivery Systems
Kutlehria, S., & Sachdeva, M. S. (2021) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2021035222 · Cited by 20
Parisi, C., Qin, K., & Fernandes, F. M. (2021) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2020.0344 · Cited by 21
“Various cell-laden platforms, such as alginate beads [336], bioprinted hydrogels [337] and ToCs [338] have been evaluated in terms of chemoresistance.”
Background3D Bioprinting for Engineering Organoids and Organ‐on‐a‐Chip: Developments and Applications
Ren, Y., Yuan, C., Liang, Q., Ba, Y., Xu, H., Weng, S., Zhang, Y., Zuo, A., Liu, S., Luo, P., et al. (2025) · Medicinal Research Reviews · doi:10.1002/med.22121 · Cited by 23
“The results of this study suggest that a 3D spheroid culture system constructed based on the determination of EC50 values may be an effective strategy for the identification of drug ‐ resistant spheroids in vitro, which could be useful for cancer research and therapy [141].”
Nested Biofabrication: Matryoshka‐Inspired Intra‐Embedded Bioprinting
Alioglu, M. A., Yilmaz, Y. O., Singh, Y. P., Nagamine, M., Celik, N., Kim, M. H., Pal, V., Gupta, D., & Ozbolat, I. T. (2023) · Small Methods · doi:10.1002/smtd.202301325 · Cited by 19
The progressive trend of modeling and drug screening systems of breast cancer bone metastasis
Azar, H. K., Gharibshahian, M., Rostami, M., Mansouri, V., Sabouri, L., Beheshtizadeh, N., & Rezaei, N. (2024) · Journal of Biological Engineering · doi:10.1186/s13036-024-00408-5 · Cited by 23
Patient-specific 3D bioprinting for in situ tissue engineering and regenerative medicine
Akilbekova, D., & Turlybekuly, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89831-7.00003-1 · Cited by 23
Alhattab, D. M., Isaioglou, I., Alshehri, S., Khan, Z. N., Susapto, H. H., Li, Y., Marghani, Y., Alghuneim, A. A., Díaz‐Rúa, R., Abdelrahman, S., et al. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00457-9 · Cited by 21
Monteiro, M. V., Rocha, M., Carvalho, M. T., Freitas, I., Amaral, A. J. R., Sousa, F. L., Gaspar, V. M., & Mano, J. F. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c11188 · Cited by 20
Shukla, P., Bera, A. K., Ghosh, A. K., Kiranmai, G., & Pati, F. (2024) · Biofabrication · doi:10.1088/1758-5090/ad586b · Cited by 18
“Since it has been shown in previous studies that cancer cell viability is different in 2D monolayer model compared to 3D bioprinted model in response to chemotherapeutic agents [48, 49, 82, 83], therefore we kept 3D bioprinted models as untreated con-trol for our study.”
In Vitro Human Cancer Models for Biomedical Applications
Choi, J. R., Kozalak, G., di Bari, I., Babar, Q., Niknam, Z., Rasmi, Y., & Yong, K. W. (2022) · Cancers · doi:10.3390/cancers14092284 · Cited by 17
“Lysyl oxidate inhibitor was able to enhance doxorubicin sensitivity of the breast cancer model [99].”
BackgroundAdvanced Hydrogels in Breast Cancer Therapy
Gao, X., Caruso, B. R., & Li, W. (2024) · Gels · doi:10.3390/gels10070479 · Cited by 18
“Addressing the high genomic instability and altered phenotypes of cells grown in 2D cultures, patient-derived organoid (PDO) 3D cultures effectively retain the characteristics of a patient’s original tumor [83–89].”
BackgroundRecent advances in 3D cell culture models in cancer drug development
Sol, Y., Michaels, A., Wang, J. Z., Niu, Y., Lin, Y., Zhu, L., Zhu, X., Wang, K., Murray, M. T., & Zhou, F. (2025) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-025-00740-y · Cited by 17
“3D Bioprinting can be applied in drug screening, the evaluation of the efficacy and toxicity of drugs and to investigate the mode-of-action of candidate drugs or drug resistance mechnisms (Bourland et al. 2018; Wang et al. 2018a, b, 2023).”
Jaiswal, C., & Mandal, B. B. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202300450 · Cited by 16
A 3D Bio-Printed-Based Model for Pancreatic Ductal Adenocarcinoma
Godier, C., Baka, Z., Lamy, L., Gribova, V., Marchal, P., Lavall�e, P., Gaffet, É., Bezdetnaya, L., & Alem, H. (2024) · Diseases · doi:10.3390/diseases12090206 · Cited by 16
The culture conditions and outputs from breast cancer cell line in vitro experiments
Ravi, M., Sneka, M. K., & Joshipura, A. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111548 · Cited by 15
Recapitulating the Cancer Microenvironment Using Bioprinting Technology for Precision Medicine
Kim, J., Jang, J., & Cho, D. (2021) · Micromachines · doi:10.3390/mi12091122 · Cited by 13
Sudhakaran, S. V., & Rath, S. N. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-04039-9_13 · Cited by 13
The Role of Biomimetic Hypoxia on Cancer Cell Behaviour in 3D Models: A Systematic Review
Liu, Y., Mohri, Z., Alsheikh, W., & Cheema, U. (2021) · Cancers · doi:10.3390/cancers13061334 · Cited by 14
“16 publications [24,25,28,32,36,47,49,55,62,82,85,89,92,99,112,124] were identified which described the process of invasion or migration or both.”
BackgroundMorán-Álvarez, A., González‐Menéndez, P., Mayo, J. C., & Sainz, R. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032717 · Cited by 15
“Those alterations that imply metabolic rewiring during low oxygen concentration in solid tumours’ cores have been found in spheroids of the bladder, prostate, ovary, breast, pancreatic, lung, and liver [42,45-48,50,51].”
BackgroundMarques, J. R. O. F., González‐Alva, P., Lin, R. Y., Fernandes, B. F., Chaurasia, A., & Dubey, N. (2023) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2023.03.005 · Cited by 12
Advancements and innovations in liquid biopsy through microfluidic technology for cancer diagnosis
Abusara, O. H., Agha, A. S. A. A., & Bardaweel, S. K. (2025) · The Analyst · doi:10.1039/d5an00105f · Cited by 16
Cancer Cell Direct Bioprinting: A Focused Review
Lobo, D. A., Ginestra, P. S., Ceretti, E., Puig, T., & Ciurana, J. (2021) · Micromachines · doi:10.3390/mi12070764 · Cited by 12
Nanocomposite Hydrogel Bioinks for 3D Bioprinting of Tumor Models
Wang, Y., Duan, Y., Yang, B., & Li, Y. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.4c00671 · Cited by 11
Self-citation
Metadata
- Authors
- Wang, Y., Shi, W., Kuss, M., Mirza, S., Qi, D., Krasnoslobodtsev, A., Zeng, J., Band, H., Band, V., & Duan, B.
- Affiliations
- Shandong University (CN)
- University of Nebraska Medical Center (US)
- First Hospital of China Medical University (CN)
- University of Nebraska at Omaha (US)
- Fred and Pamela Buffett Cancer Center (US)
- Corresponding author
- Band, Vimla
- Duan, Bin
- ORCID
- Venue
- ACS Biomaterials Science & Engineering
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-11-15
- Volume
- 4
- Issue
- 12
- Pages
- 4401-4411
- ISSN
- 2373-9878 (ISSN-L)
- OpenAlex
- W2901604183
- Cited by
- 157
- References
- 89
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 30 · 2023: 25 · 2022: 20 · 2021: 32 · 2020: 13 · 2019: 7
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- ACS Biomaterials Science & Engineering (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Nebraska Department of Health and Human Services
- University of Nebraska Medical Center
- U.S. Department of Defense (W81XWH-17-1-0616, W81XWH-14-1-0567)
- State of Nebraska
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- 3D bioprinting, breast cancer, drug resistance, doxorubicin resistance, tumor microenvironment, lysyl oxidase, obesity, apoptosis, caspase-3, ABC transporters, tumor stiffness, HER2-positive breast cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.